AstraZeneca Considering Plan to Sell Some Rights to Future Revenue on Existing Drugs -FT
June 20 2014 - 3:17PM
Dow Jones News
AstraZeneca PLC (AZN) is working with banks on a possible plan
to sell the rights to some future revenue from existing drugs, the
Financial Times reported Friday, citing people familiar with the
matter.
The plan is one of several strategic options the company is
considering, according to the report.
AstraZeneca Chief Executive Pascal Soriot has said he is looking
at ways to boost the U.K. drug maker's share price after fighting
off a takeover effort by Pfizer Inc. (PFE), including forming
cancer-treatment partnerships with rivals and making its own
acquisitions.
Website: www.ft.com
Write to nymonitoring@dowjones.com
Subscribe to WSJ: http://online.wsj.com?mod=djnwires
Pfizer (NYSE:PFE)
Historical Stock Chart
From Mar 2024 to Apr 2024
Pfizer (NYSE:PFE)
Historical Stock Chart
From Apr 2023 to Apr 2024